http://www.iht.com/articles/2007/11/21/america/assess.php


Stem cell breakthrough recasts the political debate 
By Sheryl Gay Stolberg

Wednesday, November 21, 2007 

WASHINGTON: It has been more than six years since President George W. Bush, in 
the first major televised address of his presidency, drew a stark moral line 
against the destruction of human embryos in medical research.

Since then, he has steadfastly maintained that scientists would come up with an 
alternative method of developing embryonic stem cells, one that did not involve 
killing embryos.

Critics were skeptical. But now that scientists in Japan and Wisconsin have 
apparently realized Bush's vision, the White House is saying, "I told you so."

Conservative Republican presidential hopefuls like former Governor Mitt Romney 
of Massachusetts are breathing a sigh of relief. And opponents of embryonic 
stem cell research are congratulating themselves.

The discovery that skin cells can be reprogrammed to mimic embryonic stem cells 
is likely to transform the sticky political debate over the science, a debate 
that has pitted Bush against two-thirds of the American public, including 
prominent Republicans like Nancy Reagan, and has even helped decide elections.

The findings have put people on both sides of the divide on nearly equal 
political footing. Each side can now say it has fruitful research to pursue.

Each side can even lay claim to the same scientists. The author of the new skin 
cell studies is James Thomson, the University of Wisconsin researcher who 
extracted stem cells from human embryos in the first place.

Perhaps no one outside the world of science is as acutely aware of this as 
Bush. The president and his aides have been quietly monitoring the Wisconsin 
experiments for months, receiving briefings from Elias Zerhouni, director of 
the National Institutes of Health.

On Tuesday, senior aides to Bush said he drove the experiments by holding his 
moral ground.

"This is very much in accord with the president's vision from the get-go," said 
Karl Zinsmeister, a White House domestic policy adviser who kept the president 
apprised of the work. "I don't think there's any doubt that the president's 
drawing of lines on cloning and embryo use was a positive factor in making this 
come to fruition."

Bush's critics say he should not be so quick to take credit. They note that the 
reprogramming method has some kinks to be worked out and say the research would 
never have proceeded without the initial embryo experiments. The critics say 
that far from encouraging research, Bush has stood in its way.

In 2001, in a compromise aimed at discouraging the destruction of embryos, Bush 
told federal researchers that they could work just on those stem cell lines 
already in existence. He has twice vetoed bills to ease those restrictions.

"I really don't think anybody ought to take credit in light of the six-year 
delay we've had," said Senator Arlen Specter of Pennsylvania, the lead 
Republican sponsor of the bill that Bush vetoed in July 2006. "My own view is 
that science ought to be unfettered and that every possible alternative ought 
to be explored.

"You've got a life-and-death situation here," Specter continued, "and if we can 
find something which is certifiably equivalent to embryonic stem cells, fine. 
But we are not there yet."

Embryonic stem cells are attractive to scientists because they have the 
potential to grow into any cell or tissue in the body and could, theoretically, 
be used to treat many ailments. Opponents, including Christian conservatives, 
say it is immoral to destroy embryos to obtain cells.

Early in the controversy, opponents, including Bush, often said they supported 
studies using so-called adult stem cells extracted from blood and bone marrow. 
But those cells have more limited potential than embryonic stem cells, and 
proponents of embryo experiments said it was like comparing apples to oranges. 
The reprogrammed skin cells, by contrast, appear to hold the same properties as 
embryonic stem cells, more an apples-to-apples comparison.

"We now have a situation where, ironically, despite an inability to get 
political consensus, the science has presented opportunities for a variety of 
moral views to have an outlet," Arthur Caplan, director of the Center for 
Bioethics at the University of Pennsylvania, said. "Proponents can no longer 
say that there aren't any real options."

The debate has even been a factor in some elections, like the Missouri Senate 
race last year. In that contest, Claire McCaskill, a Democrat, unseated Jim 
Talent, a Republican who opposed the research.

The race drew national attention after the actor Michael Fox, who has 
Parkinson's disease and has been a vocal advocate for stem cell studies, made a 
commercial for McCaskill.

The new findings could defuse the issue in the 2008 campaign, or at least that 
is the hope of candidates like Romney.

"This will bolster the arguments of folks like Governor Romney, who look at 
alternative types of research that they believe are more promising and don't 
have those same ethical dilemmas," said Kevin Madden, Romney's press secretary.

At the same time, scientists may well begin pursuing reprogramming with vigor, 
if only because it is easier to obtain federal money for it, said Robert 
George, a law professor at Princeton who is on the president's Council on 
Bioethics and opposes embryo experiments.

"I'm sure in their ideal world, we would be pursuing all methods, and that 
includes embryo-destructive methods," George said. "Those who want to continue 
to fight on this will no doubt continue. But the ranks are going to be reduced."

That is not to say advocates for embryonic stem cell studies plan to give up. 
Specter and other supporters of the bill to lift Bush's rules say they will try 
to turn that bill into law, if not in this administration, then in the next one.

"None of this feels like it should be one versus the other," said 
Representative Diana DeGette, Democrat of Colorado, who is sponsoring the bill 
in the House.

"That's the politicization of science."

Kirim email ke